Stockreport

Zomedica Announces Achievement of Product Development Milestones on its TRUFORMA™ Point-of-Care Diagnostic Platform

Zomedica Corp. Common Shares  (ZOM) 
US:NYSE Investor Relations: investors.zomedica.com
PDF ANN ARBOR, Mich., May 21, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM), a veterinary diagnostic and pharmaceutical company [Read more]